Pearl Huang, former Cygnal Therapeutics president and CEO
Flagship builds a new startup out of pieces from 2 of its biotechs. And a Roche vet leaves to do something new
Flagship has crafted a new startup out of pieces from a pair of fledglings in the VC’s nest. And a prominent Roche veteran who ran …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
